Why the study?
What is the prevalence of heart failure and the extent of guideline-directed pharmacological management in primary care in the UK?
What is the prevalence of heart failure and the extent of guideline-directed pharmacological management in primary care in the UK?
In UK primary care, while most heart failure patients receive an ACE inhibitor or ARB, few are titrated to target doses and many do not receive a beta-blocker, highlighting a significant gap in guideline-directed medical therapy.
No takes yet. Share an insight, caveat, or question.
GDMT remains underused and underdosed in UK primary care HF; leaves open whether system-level interventions improve target dose achievement.
Calvert et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: